LEP and astrocytoma (excluding glioblastoma): Leptin enhances sPLA2-IIA-mediated effects in 1321N1 astrocytoma cells, and sPLA2-IIA enhances leptin capacity to signal by inducing overexpression of its receptor, thereby possibly contributing to a more aggressive behaviour of the basal tumor phenotype.